Get to know us

About St. Stamford
Modern Cancer Hospital

Established in 2005, we are a Sino-Singapore joint venture hospital combining international minimally invasive technology with compassionate, patient-centered oncology care — trusted by patients in 88 countries.
about-st-stamford-international-medical

60,000+

International Consultations

88

Countries Worldwide

2,000,000+

Minimally Invasive Cases

21 Yrs

International Service Experience

6,000+

Cancer Lectures Worldwide

MCHG — Who We Are

A Global Leader in Oncology Precision Care

St. Stamford Modern Cancer Hospital Guangzhou is a joint venture of Singapore and China, specializing in cancer treatment with internationally advanced minimally invasive technology, a professional MDT medical team, and world-class caring services.

Adhering to the principle of “high starting point, high standard and high taste,” the hospital has introduced over 100 sets of large-scale equipment — from GE 128-slice spiral CT and digital mammography to nano-knife and argon-helium knife systems.

Based in China and facing the world, we have built international cooperation with more than 20 overseas medical institutions, with offices across Malaysia, Vietnam, Indonesia, the Philippines, Bangladesh, Cambodia, and Thailand.

180,000 m² Campus293 Beds400+ Staff20+ Global Offices
Hospital Qualification

Internationally Recognized Standards

Our accreditations and memberships reflect an unwavering commitment to the highest international benchmarks in oncology care.
logo-joint-comission-quality-approval

Joint Commission International (JCI)

Accredited in 2014 and re-accredited in 2017 — the highest global standard for hospital quality and safety.

Member of UICC

Member of the International Union Against Cancer, adhering to the most rigorous global oncology standards.

China Anti-Cancer Association

Officially recognized member and designated Belt & Road Integrated Oncology Medical Training Base.

Ministry of Health Approved

A formal hospital fully approved and regulated by the Ministry of Health of China since 2005.

Malaysia Penang Anti-Cancer Partner

Strategic partner of the Malaysia Penang Anti-Cancer Association for regional oncology excellence.

Trusted Across 88 Countries

Our global reach reflects the trust of patients from Asia, the Middle East, Africa, and beyond — all choosing MCHG for world-class cancer care.
Development History

Two Decades of Innovation

From a single vision in 2005 to a globally recognized oncology leader — our journey is defined by milestones of breakthrough and service.
2005
  • Singapore St. Stamford International Medical formally established
  • Designated Hospital for Members of Europe-China Joint Chamber of Commerce
2006
  • Overseas strategy officially launched
  • Jakarta, Indonesia office established
ADVANCED TECHNOLOGIES

18 precision therapies, one personalized plan.

We specialize in targeted, minimally invasive techniques that maximize precision while preserving healthy tissue and patient quality of life.

Nano-Knife Therapy

Irreversible electroporation for soft-tissue tumors. Preserves vital vessels and nerves with no thermal damage.

Cryotherapy

Argon-helium freezing destroys tumor cells with extreme precision and minimal recovery time.

Interventional Therapy

Delivers high-concentration medication directly into the tumor's blood supply, reducing systemic side effects.

Particle Implantation

Internal brachytherapy with radioactive seeds delivering targeted radiation inside the tumor site.

Targeted Therapy

Molecular-level treatment that attacks specific cancer cell pathways while sparing healthy tissue.

Integrated TCM

Traditional Chinese Medicine combined with modern oncology to support immunity and quality of life.
Read more
Services & Facilities

Everything Centered on the Patient

St. Stamford Modern Cancer Hospital Guangzhou has a total construction area of 180,000 square meters, 293 beds, and more than 400 employees. With a warm, comfortable environment and advanced medical equipment, we provide high-quality services for patients from around the world.

Adhering to the service tenet of “everything is patient-centered,” we provide each patient with humanized, comprehensive, and high-quality medical care from arrival to recovery.

Free Consultation

Hospitalization Guide

Multi-lingual Staff

Travel Assistance

Business Insurance

24/7 Patient Support

Hospital Environment

Healing Begins with Comfort

Our facility is designed to foster calm, dignity, and recovery — a space where world-class medical care meets compassionate hospitality.
Get Started Today

Ready to Begin Your Treatment Journey?

Our patient coordinators are available 24/7 to review your diagnosis, explain which technologies apply, and arrange a free multidisciplinary case review.
Book a Free Consultation

Prof. Song Shijun

Chief Expert of the Oncology Department
Chief Physician • Professor

Introduction

Prof. Song Shijun is a professor, chief physician, and CPC member with over 40 years of clinical experience in oncology. He specializes in chemotherapy, minimally invasive therapy, biotherapy, and targeted therapy for various solid tumors.

Medical Experience

  • Over 40 years of clinical oncology experience.
  • Chief Expert of the Oncology Department and leader of the Multidisciplinary Team (MDT).
  • Specialized in chemotherapy, minimally invasive therapy, targeted therapy, biotherapy, and integrated cancer treatment.
  • Extensive experience in treating complex and advanced-stage malignant tumors.
  • Pioneer in integrating minimally invasive treatment with immunotherapy and precision medicine.
  • Has successfully treated more than 10,000 cancer patients, with many achieving long-term survival exceeding 10 years.
  • Frequently participates in international oncology conferences and promotes medical collaboration across Southeast Asia.

Research Areas

  • Precision Oncology
  • Minimally Invasive Cancer Therapy
  • Targeted Therapy
  • Biotherapy and Immunotherapy
  • Multidisciplinary Team (MDT) Cancer Management
  • Radiofrequency Ablation (RFA)
  • Palliative Care for Advanced Cancer
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Molecular Biomarkers in Cancer
  • Personalized Cancer Treatment Strategies
Book Consultation

Prof. Dai Wenyan

Director of Oncology Department · Director of Breast Cancer Center
Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. Specializing in precision minimally invasive therapy, she has treated more than 5,000 international patients, focusing on improving the quality of life and survival rates for advanced-stage cancer patients.

Medical Experience

  • Over 20 years of clinical work in oncology and cancer research.
  • Expertise in multidisciplinary (MDT) consultation and personalized treatment planning.
  • Completed advanced studies at the National University of Singapore (2015) and Sun Yat-sen University Cancer Center (2017 & 2019).
  • Specialist in minimally invasive techniques including interventional therapy, seed implantation, and cryotherapy.

Research Areas

  • Precision minimally invasive cancer treatment technologies.
  • Combination of targeted therapy, immunotherapy, and chemotherapy for refractory tumors.
  • Endoscopic diagnosis and treatment of malignant tumors.
  • Integrated medical models for advanced-stage cancer management.
Book Consultation

Ma Xiaoying

Director of Oncology Department
Associate Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. She specializes in minimally invasive precision treatments, combining targeted therapy and immunotherapy to provide individualized plans for advanced cancer patients, focusing on improving their quality of life.

Medical Experience

  • More than 20 years of extensive clinical work in the field of oncology.
  • Expertise in treating advanced and refractory tumors with rich clinical results.
  • Successfully treated over 5,000 international patients, particularly from Southeast Asia.
  • Proficient in implementing multidisciplinary (MDT) treatment plans and managing cancer complications.

Research Areas

  • Integration of minimally invasive technologies (interventional therapy, cryotherapy, microwave ablation) with molecular targeted therapy.
  • Individualized and comprehensive treatment protocols for solid tumors.
  • Advanced techniques in tumor endoscopy for both diagnosis and treatment.
  • Research on biological immunotherapy and endocrine therapy for late-stage cancers.
Book Consultation

Dr. Wang Baoli

Oncology Specialist
Associate Chief Physician

Introduction

Nearly 20 years of clinical oncology experience in China's top-tier Grade A tertiary hospitals. Expert in minimally invasive interventional therapy, chemotherapy, and combined targeted-immunotherapy, focusing on complex cancers and advocating a Multidisciplinary Team (MDT) treatment approach.

Medical Experience

  • Member, Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
  • Member, Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
  • Member, Interventional Medicine Professional Committee, Guangzhou Medical Association
  • Member, Liver Cancer Professional Committee, Tumor Rehabilitation Branch, Chinese Geriatrics Society
  • Member, Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association
  • Published 5 papers in core medical journals and 1 SCI-indexed paper
  • Awarded 1 Third Prize for Military Medical Achievements
  • Participated in 1 provincial-level government-funded research project

Research Areas

  • Integrated minimally invasive therapy for tumors
  • Multidisciplinary Team (MDT) precision personalized diagnosis and treatment model
  • Application of combined targeted and immunotherapy strategies in oncology
Book Consultation

About

Introduction

Medical Experience

Research Areas

Book Consultation